1157 related articles for article (PubMed ID: 19319544)
1. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
2. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease.
Sagare AP; Bell RD; Zlokovic BV
Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132
[TBL] [Abstract][Full Text] [Related]
3. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
4. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
5. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular defects and faulty amyloid-β vascular clearance in Alzheimer's disease.
Sagare AP; Bell RD; Zlokovic BV
J Alzheimers Dis; 2013; 33 Suppl 1(0 1):S87-100. PubMed ID: 22751174
[TBL] [Abstract][Full Text] [Related]
7. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
9. The Neurovascular Unit Dysfunction in Alzheimer's Disease.
Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic targets in the neurovascular pathway in Alzheimer's disease.
Zlokovic BV
Neurotherapeutics; 2008 Jul; 5(3):409-14. PubMed ID: 18625452
[TBL] [Abstract][Full Text] [Related]
11. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
12. Neurovascular dysfunction and vascular amyloid accumulation as early events in Alzheimer's disease.
Apátiga-Pérez R; Soto-Rojas LO; Campa-Córdoba BB; Luna-Viramontes NI; Cuevas E; Villanueva-Fierro I; Ontiveros-Torres MA; Bravo-Muñoz M; Flores-Rodríguez P; Garcés-Ramirez L; de la Cruz F; Montiel-Sosa JF; Pacheco-Herrero M; Luna-Muñoz J
Metab Brain Dis; 2022 Jan; 37(1):39-50. PubMed ID: 34406560
[TBL] [Abstract][Full Text] [Related]
13. Pathological changes within the cerebral vasculature in Alzheimer's disease: New perspectives.
Fisher RA; Miners JS; Love S
Brain Pathol; 2022 Nov; 32(6):e13061. PubMed ID: 35289012
[TBL] [Abstract][Full Text] [Related]
14. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice.
Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM
Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
16. SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells.
Bell RD; Deane R; Chow N; Long X; Sagare A; Singh I; Streb JW; Guo H; Rubio A; Van Nostrand W; Miano JM; Zlokovic BV
Nat Cell Biol; 2009 Feb; 11(2):143-53. PubMed ID: 19098903
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulants for Treatment of Alzheimer's Disease.
Grossmann K
J Alzheimers Dis; 2020; 77(4):1373-1382. PubMed ID: 32925057
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
19. Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease.
Yamazaki Y; Kanekiyo T
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902142
[TBL] [Abstract][Full Text] [Related]
20. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress.
Uekawa K; Hattori Y; Ahn SJ; Seo J; Casey N; Anfray A; Zhou P; Luo W; Anrather J; Park L; Iadecola C
Mol Neurodegener; 2023 Oct; 18(1):73. PubMed ID: 37789345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
